ROYAL BANK OF CANADA - AMPHASTAR PHARMACEUTICALS IN ownership

AMPHASTAR PHARMACEUTICALS IN's ticker is AMPH and the CUSIP is 03209R103. A total of 250 filers reported holding AMPHASTAR PHARMACEUTICALS IN in Q3 2023. The put-call ratio across all filers is 1.02 and the average weighting 0.1%.

Quarter-by-quarter ownership
ROYAL BANK OF CANADA ownership history of AMPHASTAR PHARMACEUTICALS IN
ValueSharesWeighting
Q3 2023$267,000
-81.7%
5,789
-77.3%
0.00%
Q2 2023$1,463,000
+881.9%
25,449
+538.0%
0.00%
Q1 2023$149,000
-38.9%
3,989
-54.5%
0.00%
Q4 2022$244,000
+117.9%
8,766
+118.5%
0.00%
Q3 2022$112,000
-4.3%
4,011
+19.1%
0.00%
Q2 2022$117,000
-87.7%
3,367
-87.3%
0.00%
Q1 2022$954,000
+448.3%
26,585
+257.2%
0.00%
Q4 2021$174,000
+100.0%
7,443
+64.5%
0.00%
Q3 2021$87,000
+22.5%
4,524
+28.0%
0.00%
Q2 2021$71,000
+294.4%
3,534
+253.4%
0.00%
Q1 2021$18,000
-94.1%
1,000
-93.4%
0.00%
Q4 2020$307,000
+8.1%
15,261
+0.7%
0.00%
Q3 2020$284,000
-6.9%
15,161
+11.7%
0.00%
Q2 2020$305,000
+45.9%
13,579
-3.4%
0.00%
Q1 2020$209,000
+770.8%
14,050
+1008.0%
0.00%
Q4 2019$24,000
-29.4%
1,268
-25.4%
0.00%
Q3 2019$34,000
-8.1%
1,700
-2.0%
0.00%
Q2 2019$37,000
+5.7%
1,735
+1.9%
0.00%
Q1 2019$35,000
-52.7%
1,703
-54.0%
0.00%
Q4 2018$74,000
-22.9%
3,700
-26.1%
0.00%
Q3 2018$96,000
+585.7%
5,005
+456.1%
0.00%
Q2 2018$14,000
-17.6%
900
-2.4%
0.00%
Q1 2018$17,0000.0%922
+2.4%
0.00%
Q4 2017$17,000
-70.2%
900
-72.0%
0.00%
Q3 2017$57,000
+256.2%
3,217
+252.4%
0.00%
Q2 2017$16,000
+6.7%
913
-9.2%
0.00%
Q1 2017$15,000
-94.4%
1,006
-93.0%
0.00%
Q4 2016$267,000
+19.2%
14,474
+22.5%
0.00%
Q3 2016$224,000
+761.5%
11,819
+650.9%
0.00%
Q2 2016$26,000
+271.4%
1,574
+162.3%
0.00%
Q1 2016$7,000
+600.0%
600
+659.5%
0.00%
Q4 2015$1,000
-90.0%
79
-91.3%
0.00%
Q3 2015$10,000
-64.3%
907
-42.7%
0.00%
Q2 2015$28,000
-3.4%
1,582
-37.1%
0.00%
Q4 2014$29,0000.0%2,516
+0.6%
0.00%
Q3 2014$29,0002,5000.00%
Other shareholders
AMPHASTAR PHARMACEUTICALS IN shareholders Q3 2023
NameSharesValueWeighting ↓
LAM GROUP, INC. 130,250$3,649,6053.75%
SHAKER INVESTMENTS LLC/OH 81,287$2,277,6621.41%
Mesirow Institutional Investment Management, Inc. 374,414$10,491,0801.38%
OBERWEIS ASSET MANAGEMENT INC/ 134,000$3,754,6800.80%
Portolan Capital Management 270,791$7,587,5640.75%
Hillsdale Investment Management Inc. 172,238$4,826,1090.41%
Capital Impact Advisors, LLC 14,669$411,0250.40%
Watershed Asset Management, L.L.C. 9,555$267,7310.34%
Quantedge Capital Pte Ltd 35,153$984,9870.33%
FEDERATED HERMES, INC. 3,284,217$92,023,7600.25%
View complete list of AMPHASTAR PHARMACEUTICALS IN shareholders